U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H10O6
Molecular Weight 286.2363
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KAEMPFEROL

SMILES

OC1=CC=C(C=C1)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O

InChI

InChIKey=IYRMWMYZSQPJKC-UHFFFAOYSA-N
InChI=1S/C15H10O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,16-18,20H

HIDE SMILES / InChI

Molecular Formula C15H10O6
Molecular Weight 286.2363
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Kaempferol (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a flavonoid found in many edible plants (e.g. tea, broccoli, cabbage, kale, beans, endive, leek, tomato, strawberries and grapes) and in plants or botanical products commonly used in traditional medicine (e.g. Ginkgo biloba, Tilia spp, Equisetum spp, Moringa oleifera, Sophora japonica and propolis). Numerous preclinical studies have shown that kaempferol and some glycosides of kaempferol have a wide range of pharmacological activities, including antioxidant, anti-inflammatory, antimicrobial, anticancer, cardioprotective, neuroprotective, antidiabetic, anti-osteoporotic, estrogenic/antiestrogenic, anxiolytic, analgesic and antiallergic activities.

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.43 μg/mL
6 mg/kg single, oral
dose: 6 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
KAEMPFEROL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
17.72 mg × h/L
6 mg/kg single, oral
dose: 6 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
KAEMPFEROL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
5.11 h
6 mg/kg single, oral
dose: 6 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
KAEMPFEROL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Antioxidative phenolic compounds isolated from almond skins (Prunus amygdalus Batsch).
2002-04-10
Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries.
2002-04-10
Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
2002-03-27
Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols.
2002-03-15
Qualitative and quantitative chromatographic investigation of flavonoids in Bellis perennis L.
2002-03-06
Flavonoids from the flowers of Prunus spinosa L.
2002-03-06
Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter.
2002-03-01
Antioxidant activity of flavonoids from Licania licaniaeflora.
2002-03
Hepatoprotective principles from the flowers of Tilia argentea (linden): structure requirements of tiliroside and mechanisms of action.
2002-03
Phytochemical and pharmacological analysis of Bauhinia microstachya (Raddi) Macbr. (Leguminosae).
2002-02-12
The role of UV-B radiation in aquatic and terrestrial ecosystems--an experimental and functional analysis of the evolution of UV-absorbing compounds.
2002-02
Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9.
2002-02
Isolation and characterization of stelladerol, a new antioxidant naphthalene glycoside, and other antioxidant glycosides from edible daylily (hemerocallis) flowers.
2002-01-02
Flavonoid gene expression and UV photoprotection in transgenic and mutant Petunia leaves.
2002-01
A pharmacophore for human pregnane X receptor ligands.
2002-01
Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols.
2001-12-21
Ethyl m-digallate from red maple, Acer rubrum L., as the major resistance factor to forest tent caterpillar, Malacosoma disstria Hbn.
2001-12
Proposed active constituents of Dipladenia martiana.
2001-12
Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba.
2001-12
A new C-methylated flavonoid glycoside from Pinus densiflora.
2001-12
Flavonoids and UV photoprotection in Arabidopsis mutants.
2001-11-29
Kaempferol and its glycosides in the seeds hair of Asclepias syriaca L.
2001-11-20
Direct extraction of specific pharmacophoric flavonoids from gingko leaves using a molecularly imprinted polymer for quercetin.
2001-11-16
Kaempferol, isorhamnetin and their glycosides in the flowers of Asclepias syriaca L.
2001-11-06
Effects of flavonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils.
2001-11-01
In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species.
2001-11
A stabilized flavonoid glycoside in heat-treated Cassia alata leaves and its structural elucidation.
2001-11
Flavonol glycosides from the flowers of Bellis perennis.
2001-11
Phenolic compounds in seven South American Ilex species.
2001-11
Antioxidant ability of various flavonoids against DPPH radicals and LDL oxidation.
2001-10
Antioxidative components from the aerial parts of Lactuca scariola L.
2001-10
Effect of plant growth temperature on antioxidant capacity in strawberry.
2001-10
Indolopyridoquinazoline alkaloid from Leptothyrsa sprucei.
2001-10
Flavonol glycosides from the stems of Trigonella foenum-graecum.
2001-10
Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3.
2001-09-15
Alkaline phosphatase from rat liver and kidney is differentially modulated.
2001-09
Determination of flavonoids and stilbenes in red wine and related biological products by HPLC and HPLC-ESI-MS-MS.
2001-09
Polyphenolic compounds: interactions with the gut and implications for human health.
2001-09
Antipruritic and antidermatitic effect of extract and compounds of Impatiens balsamina L. in atopic dermatitis model NC mice.
2001-09
Electrochemical behaviors of quercetin and kaempferol in neutral buffer solution.
2001-08
Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat.
2001-08
Four new isoflavone triglycosides from Sophora japonica.
2001-08
Medicinal foodstuffs. XXV. Hepatoprotective principle and structures of ionone glucoside, phenethyl glycoside, and flavonol oligoglycosides from young seedpods of garden peas, Pisum sativum L.
2001-08
Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry (Rubus idaeus) jams.
2001-08
Cytotoxicity and lipid peroxidation-inhibiting activity of flavonoids.
2001-08
Inhibitory activity for chitin synthase II from Saccharomyces cerevisiae by tannins and related compounds.
2001-08
[Comparison of photometric, electrochemical and post-column fluorescence detection for the determination of flavonoids by HPLC].
2001-06
Flavonoids and urate antioxidant interplay in plasma oxidative stress.
2001-05
Medicinal and ethnoveterinary remedies of hunters in Trinidad.
2001
Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761).
2001
Patents

Sample Use Guides

humans: orally as a component of plant (e.g. Elaeagnus Angustifolia or Ginkgo Biloba) extracts. mice: 100 mg/kg/d, p. o. for 6 weeks. rats: 20 mg/kg; i.p. daily for a period of 28 days.
Route of Administration: Other
50 μM of kaempferol specifically inhibited the cell viability by approximately 40% in Miapaca-2 cells, 15% in Panc-1 cells, and 10% in SNU-213 cells
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:48:00 GMT 2025
Edited
by admin
on Mon Mar 31 18:48:00 GMT 2025
Record UNII
731P2LE49E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KAEMPFEROL
HSDB   INCI   MI   USP-RS  
INCI  
Official Name English
PELARGIDENOLON 1497
Preferred Name English
CI 75640
Common Name English
KAEMPFEROL [IARC]
Common Name English
SWARTZIOL
Common Name English
NIMBECETIN
Common Name English
NSC-656277
Code English
3'-DEOXYQUERCETIN
Common Name English
3,4',5,7-TETRAHYDROXYFLAVONE
Systematic Name English
KAEMPFEROL (CONSTITUENT OF GINKGO) [DSC]
Common Name English
PELARGIDENON
Common Name English
KAEMPHEROL
Common Name English
RHAMNOLUTEIN
Common Name English
4H-1-BENZOPYRAN-4-ONE, 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-
Systematic Name English
3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
Systematic Name English
5,7,4'-TRIHYDROXYFLAVONOL
Systematic Name English
POPULNETIN
Common Name English
FLAVONE, 3,4',5,7-TETRAHYDROXY-
Systematic Name English
KAMPCETIN
Common Name English
ROBIGENIN
Common Name English
C.I. 75640
Common Name English
KAEMPFEROL [USP-RS]
Common Name English
KAEMPFEROL [HSDB]
Common Name English
KAEMPFEROL [MI]
Common Name English
INDIGO YELLOW
Common Name English
NSC-407289
Code English
TRIFOLITIN
Common Name English
Classification Tree Code System Code
DSLD 1221 (Number of products:6)
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
Code System Code Type Description
WIKIPEDIA
KAEMPFEROL
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
EPA CompTox
DTXSID7020768
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
NCI_THESAURUS
C68457
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
FDA UNII
731P2LE49E
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
CHEBI
28499
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
NSC
656277
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
PUBCHEM
5280863
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
HSDB
7703
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-287-6
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
DRUG BANK
DB01852
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
NSC
407289
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
CHEBI
58573
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
MERCK INDEX
m6592
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY Merck Index
SMS_ID
300000051273
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
CAS
520-18-3
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
RS_ITEM_NUM
1354900
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
MESH
C006552
Created by admin on Mon Mar 31 18:48:00 GMT 2025 , Edited by admin on Mon Mar 31 18:48:00 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
The compound was screened for it's antioxidant capacity in the DPPH assay, and displayed a high antioxidant activity, with an IC50 value of 89.7 uM.
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
TRANSPORTER -> INHIBITOR
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT